Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian W Bigger

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Journal of Neuroinflammation|February 7, 2019
Non-myeloablative busulfan chimeric mouse models are less pro-inflammatory than head-shielded irradiation for studying immune cell interactions in brain tumoursA Saam Youshani, Samuel Rowlston, Claire O'Leary, et al.
EMBO Molecular Medicine|June 10, 2018
Brain-targeted stem cell gene therapy corrects mucopolysaccharidosis type II via multiple mechanismsHélène Fe Gleitz, Ai Yin Liao, James R Cook, et al.
Gastroenterology|May 16, 2006
The bone marrow functionally contributes to liver fibrosisFrancesco P Russo, Malcolm R Alison, Brian W Bigger, et al.
Scientific Reports|October 3, 2019
Post-transplant laronidase augmentation for children with Hurler syndrome: biochemical outcomesTroy C Lund, Weston P Miller, Ai Yin Liao, et al.
Journal of Inherited Metabolic Disease|December 21, 2010
Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseasesKia Jane Langford-Smith, Jean Mercer, June Petty, et al.
The Journal of Biological Chemistry|August 30, 2011
Mucopolysaccharidosis type I, unique structure of accumulated heparan sulfate and increased N-sulfotransferase activity in mice lacking α-l-iduronidaseRebecca J Holley, Audrey Deligny, Wei Wei, et al.
Molecular Genetics and Metabolism|February 3, 2016
Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10 year combined experience of 2 centresArunabha Ghosh, Weston Miller, Paul J Orchard, et al.
Molecular Genetics and Metabolism|July 28, 2009
Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB miceMarcelina Malinowska, Fiona L Wilkinson, William Bennett, et al.
Human Gene Therapy|May 22, 2023
Fusion of Rabies Virus Glycoprotein or gh625 to Iduronate-2-Sulfatase for the Treatment of Mucopolysaccharidosis Type IIShaun R Wood, Ahsan Chaudrhy, Stuart Ellison, et al.
Haematologica|February 29, 2012
Hematopoietic stem cell transplantation improves the high incidence of neutralizing allo-antibodies observed in Hurler's syndrome after pharmacological enzyme replacement therapyMuhammad Ameer Saif, Brian W Bigger, Karen E Brookes, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Journal of Neuroinflammation|February 7, 2019
Non-myeloablative busulfan chimeric mouse models are less pro-inflammatory than head-shielded irradiation for studying immune cell interactions in brain tumoursA Saam Youshani, Samuel Rowlston, Claire O'Leary, et al.
EMBO Molecular Medicine|June 10, 2018
Brain-targeted stem cell gene therapy corrects mucopolysaccharidosis type II via multiple mechanismsHélène Fe Gleitz, Ai Yin Liao, James R Cook, et al.
Gastroenterology|May 16, 2006
The bone marrow functionally contributes to liver fibrosisFrancesco P Russo, Malcolm R Alison, Brian W Bigger, et al.
Scientific Reports|October 3, 2019
Post-transplant laronidase augmentation for children with Hurler syndrome: biochemical outcomesTroy C Lund, Weston P Miller, Ai Yin Liao, et al.
Journal of Inherited Metabolic Disease|December 21, 2010
Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseasesKia Jane Langford-Smith, Jean Mercer, June Petty, et al.
The Journal of Biological Chemistry|August 30, 2011
Mucopolysaccharidosis type I, unique structure of accumulated heparan sulfate and increased N-sulfotransferase activity in mice lacking α-l-iduronidaseRebecca J Holley, Audrey Deligny, Wei Wei, et al.
Molecular Genetics and Metabolism|February 3, 2016
Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10 year combined experience of 2 centresArunabha Ghosh, Weston Miller, Paul J Orchard, et al.
Molecular Genetics and Metabolism|July 28, 2009
Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB miceMarcelina Malinowska, Fiona L Wilkinson, William Bennett, et al.
Human Gene Therapy|May 22, 2023
Fusion of Rabies Virus Glycoprotein or gh625 to Iduronate-2-Sulfatase for the Treatment of Mucopolysaccharidosis Type IIShaun R Wood, Ahsan Chaudrhy, Stuart Ellison, et al.
Haematologica|February 29, 2012
Hematopoietic stem cell transplantation improves the high incidence of neutralizing allo-antibodies observed in Hurler's syndrome after pharmacological enzyme replacement therapyMuhammad Ameer Saif, Brian W Bigger, Karen E Brookes, et al.
Pageof 7